Barry Nelkin

Medicine & Life Sciences

1. Medullary Thyroid cancer 100%
2. Calcitonin 60%
3. Small Cell Lung Carcinoma 44%
4. Genes 32%
5. Growth 30%
6. Neoplasms 27%
7. Mitogen-Activated Protein Kinase Kinases 24%
8. ras Genes 24%
9. DNA 23%
10. Cell Line 22%
11. Methyltransferases 15%
12. dinaciclib 15%
13. Thyroid Neoplasms 14%
14. Leukemia Inhibitory Factor 14%
15. Methylation 14%
16. Neuroendocrine Tumors 13%
17. DNA Methylation 13%
18. Messenger RNA 13%
19. Lung Neoplasms 13%
20. Pancreatic Neoplasms 13%
21. Cyclin-Dependent Kinase 5 12%
22. Chromosomes, Human, Pair 11 12%
23. Loss of Heterozygosity 12%
24. Nuclear Matrix 12%
25. CEP 751 12%
26. Pheochromocytoma 11%
27. AZD 6244 11%
28. Heterografts 10%
29. Cyclin-Dependent Kinases 10%
30. Gene Expression 10%
31. Chromosomes 10%
32. Complementary DNA 10%
33. Transcription Factors 10%
34. Calcitonin Gene-Related Peptide 10%
35. Tretinoin 9%
36. Mutation 9%
37. myc Genes 9%
38. Phenotype 8%
39. MK 2206 8%
40. Polyamines 8%
41. cabozantinib 8%
42. Lung 8%
43. Extracellular Signal-Regulated MAP Kinases 8%
44. Cell Cycle Checkpoints 8%
45. Colonic Neoplasms 8%
46. Protein-Tyrosine Kinases 8%
47. trametinib 8%
48. Cytosine 8%
49. pazopanib 8%
50. Drosophila 8%